×
Premier Receivables 2012-2025 | PINC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Premier receivables from 2012 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
Premier Receivables 2012-2025 | PINC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Premier receivables from 2012 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$136B
CVS Health (CVS)
$78.4B
Elevance Health (ELV)
$62.6B
Cencora (COR)
$56.8B
DiDi Global (DIDIY)
$26.9B
Labcorp Holdings (LH)
$20.4B
Natera (NTRA)
$19B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$14B
CochLear (CHEOY)
$13.1B
Solventum (SOLV)
$12.7B
ICON (ICLR)
$11.6B
Revvity (RVTY)
$11B
Viatris (VTRS)
$10.4B
Avantor (AVTR)
$9.1B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$8.9B
HealthEquity (HQY)
$8.4B
Caris Life Sciences,�Inc (CAI)
$7.7B
Charles River Laboratories (CRL)
$7.6B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.1B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.5B
Organon (OGN)
$2.5B
Alignment Healthcare (ALHC)
$2.5B
GeneDx Holdings (WGS)
$2.2B
Progyny (PGNY)
$1.9B